Canada Just Made It Easier for Overseas Pharmacists: PEBC's New 2027 Pathway Explained

Written by

Co-Author

Created On : Aug 14, 2026 Updated On : Aug 14, 2026 3 Min

 

I'm Dr. Akram Ahmad, and I've spent years guiding pharmacists through their journey to practise abroad. So when I read PEBC's announcement about this change, I'll be honest, I was genuinely pleased. This is one of those rare regulatory updates that actually makes life easier for candidates, not harder. Let me walk you through exactly what's changing and what it means for you.

The Short Version

Starting January 2027, international pharmacy graduates (IPGs) will no longer need to pass the Pharmacist Evaluating Examination to get certified by PEBC, the Pharmacy Examining Board of Canada. You'll go straight to Part I (MCQ) of the Pharmacist Qualifying Examination, as long as your Pharmacist Document Evaluation is current. One less high-stakes exam standing between you and practising pharmacy in Canada.

This Builds on an Earlier Change, But Now It's for Everyone

If you've been researching this for a while, you might already know that PEBC introduced a similar shortcut back in May 2025 but that one only applied to a specific group: graduates of CCAPP or ACPE-accredited pharmacy programs, or candidates who'd already held a licensed pharmacist role for a year in certain approved countries. If you didn't fit one of those narrow categories, you still had to sit the Evaluating Exam.

This January 2027 change is much bigger. It removes the Evaluating Examination requirement for every international pharmacy graduate, not just the previously-eligible subset. If the 2025 pathway didn't apply to you, this one does.

Why Canada Is Doing This

I don't think this is a coincidence. Canada has a well-documented pharmacist shortage, particularly outside its biggest cities, and every extra exam stage in a certification pathway adds months, sometimes years before a qualified pharmacist can actually start working. PEBC streamlining this process is a practical response to a real workforce need, and it's good news if you're a BPharm or PharmD graduate looking at Canada as an option.

Key Dates You Need to Know

WhatWhen
New pathway takes effectJanuary 2027
Last-ever Pharmacist Evaluating ExaminationOctober 2026
Withdrawal window for Oct 2026 exam (full refund, if paid on/after April 30, 2026)August 10–24, 2026
Next Pharmacist Qualifying Examination (Part I MCQ / Part II OSCE)February 2027
Part I (MCQ) application opens in Candidate PortalBy August 28, 2026
Application deadline for February 2027 Qualifying Exam12:00 pm ET, November 19, 2026
Document Evaluation validity5 years from approval
Maximum attempts (Part I and Part II each)4 attempts

Which Situation Applies to You?

If you're just starting out, this is the group most of you reading this fall into.

From January 2027, once your Document Evaluation is complete and valid, you go straight to Part I (MCQ) of the Qualifying Exam. No Evaluating Exam needed. Your first real step is simply getting your Document Evaluation done, that's the foundation everything else builds on, and it's worth starting now rather than waiting for January.

If you already passed the Evaluating Examination, good news, this change doesn't affect you negatively at all.

You can still apply for Part I (MCQ) and Part II (OSCE) in whichever order suits you, including the same sitting, exactly as before.

If you're currently enrolled in the October 2026 Evaluating Exam, you now have a genuine choice.

Taking it is optional, not mandatory. If you sit it and pass, you get the bonus of being able to attempt Part I and Part II in any order. If you'd rather skip it, you can withdraw for a full refund between August 10–24, 2026 (if you paid on or after April 30, 2026), and you'll simply follow the same straightforward pathway as new candidates.

If you already tried and failed the Evaluating Exam, even if you used up all your attempts, you're not stuck.

You can continue toward PEBC certification under the new pathway, as long as your Document Evaluation is valid. If your old Candidate Portal account was closed, PEBC will reactivate it, you don't need to start a new one.

OPRA vs PEBC in 2027: Which Is Actually Easier?

Here's the honest comparison I give every pharmacist who asks me whether to aim for Canada or Australia.

Even after this change, PEBC still requires you to clear two separate high-stakes exam stages, Part I (MCQ) and Part II (OSCE), each with a cap of 4 attempts. What's changed is that you no longer need to clear the Evaluating Exam first. That's a real simplification, but it doesn't turn PEBC into an easy pathway. It's a shorter tough pathway, not a soft one.

OPRA, Australia's entry exam for overseas pharmacists, is structurally simpler at the first hurdle.

It's a single knowledge exam, there's no official cap on attempts, and it's held three times a year, March, July, and November, giving you more regular chances if you don't clear it the first time. That said, OPRA is genuinely just the beginning in Australia too: after passing it, you still need provisional registration, 1,575 hours of supervised internship, and then the Intern Written and Oral Exams before you're fully registered. Neither country hands you a fast, easy finish line both ask for real commitment across multiple stages.

So who should this PEBC change actually excite?

Honestly, it's most valuable for pharmacists who are already living in Canada, already have family or immigration ties there, or were already committed to the PEBC pathway before this announcement. For that group, this is a genuine, meaningful improvement, one less exam, less time, less cost. But if you're a pharmacist choosing fresh between Australia and Canada with no strong pull toward either, OPRA's more forgiving entry point still makes Australia the comparatively easier door to walk through first. This change makes Canada better. It doesn't yet make Canada easier than Australia.

What I'd Recommend Doing Right Now

  1. Get your Pharmacist Document Evaluation started immediately if you haven't already. This is the one step nothing else can happen without, and it takes real time to process. Don't wait until January 2027 to begin this.
  2. Check your Document Evaluation's validity window. It's valid for 5 years, if yours is close to expiring before your intended exam sitting, you'll need a Document Re-Evaluation first.
  3. If you're currently preparing for the October 2026 Evaluating Exam, have an honest conversation with yourself (or with us) about whether sitting it still makes sense for your situation, now that it's optional.

Start preparing for Part I (MCQ) early. PEBC is also introducing a real-time readiness-assessment tool from mid-August 2026, use it. The fewer surprises on exam day, the better, especially with a 4-attempt cap.

Thinking about Canada as your next step? I've guided pharmacists through exactly this kind of transition for years, and I'd genuinely like to help you plan yours the right way. Book a free 1:1 counselling session and let's map out your path under this new pathway.   Dr. Akram Ahmad

FAQs

Do I still need to complete PEBC's Document Evaluation?

Yes. This is unchanged, every international pharmacy graduate still needs a current, valid Document Evaluation before applying for the Qualifying Examination.

When is the last Pharmacist Evaluating Examination?

October 2026. After that, PEBC will no longer offer it at all.

Is the October 2026 Evaluating Exam mandatory if I'm already enrolled?

No, it's now optional. You can take it for the practice and detailed feedback report, or withdraw for a full refund if you applied and paid on or after April 30, 2026 (withdrawal window: August 10-24, 2026).

Do I need remediation if I failed the Evaluating Exam multiple times in the past?

No. Remediation tied to a previous Evaluating Exam attempt is not required before starting Part I (MCQ) under the new pathway, as long as your Document Evaluation is valid.

How many attempts do I get at Part I (MCQ) and Part II (OSCE)?

Four attempts at each, same as before, this hasn't changed.

Does this affect the Pharmacy Technician pathway too?

Yes. From January 2027, candidates with a valid Pharmacist Document Evaluation can apply directly for the Pharmacy Technician Qualifying Examination as well.

I'm a graduate of a US ACPE-accredited PharmD program, does this change affect me?

No. This change is specific to the international pharmacy graduate pathway and doesn't alter anything for US ACPE graduates.

What happens to my Document Evaluation once I pass Part I (MCQ)?

It becomes valid for the rest of your certification pathway from that point on, you won't need to worry about its 5-year expiry again.

Where can I confirm all of this directly?

PEBC's own website is the official source for this change. If anything anywhere (including this blog) ever seems to conflict with what's on their site, always go with what PEBC states directly.
Dr. Akram Ahmad

BPharm, PharmD, PhD (University of Sydney, Australia)

about the author

Dr. Akram Ahmad, PhD, is a clinical pharmacist, researcher and healthcare educator with more than 14 years of teaching and research experience across India, Malaysia and Australia. He completed his PhD at the Faculty of Medicine and Health, University of Sydney, where his research focused on medication safety and health outcomes, and has authored over 110 peer-reviewed publications in international journals.

He is the founder and CEO of Academically Global, a healthcare education company that has supported more than 10,000 doctors, dentists, pharmacists, nurses and physiotherapists across 88 countries, and of Jobslly, a healthcare careers platform. He is a TEDx speaker and has been featured on JioHotstar and Wikipedia, and has mentored healthcare professionals in both university and industry settings.

Dr. Ahmad writes and speaks on two areas in particular: international licensing pathways for healthcare professionals, including the AMC (Australia), USMLE (USA), OPRA (Australia and New Zealand), PEBC (Canada), PSI (Ireland) and DHA/MOH (Gulf) examinations, and non-clinical career transitions into pharmacovigilance, Medical Affairs/MSL, clinical research, medical writing and regulatory affairs.

His goal with every article is simple: to give healthcare professionals accurate, practical information about global career options that no one taught them in college.

Find him on:    Google Scholar · Wikipedia · ORCID · YouTube